TRICARE to pay ambulance crews separately for blood in five-year trial starting 2027
A Defense Health Agency demonstration will add a payment for blood products and transfusion services on top of the standard ambulance rate. TRICARE For Life beneficiaries face a 25 percent copayment on the add-on.
The Defense Health Agency will begin paying ambulance providers separately for blood and transfusion services on Jan. 1, 2027, under a five-year TRICARE demonstration project announced in the Federal Register on Monday[1].
The notice, filed for public inspection July 2 and dated June 30, is a test of whether a payment change improves survival for trauma patients who are bleeding heavily, and whether the government comes out ahead on total cost[1]. It also bears on a practical question for TRICARE beneficiaries, including active-duty members and their families: whether the ambulance that reaches them is able to carry blood at all[1].
How the payment works
TRICARE is required by law to pay for ground and air ambulance service under the Medicare Ambulance Fee Schedule, which folds the cost of supplies into a single base rate, the notice says[1]. In 2025, that base rate was $446.37 for basic life support, $530.06 for advanced life support level 1 (ALS1) and $767.20 for advanced life support level 2 (ALS2)[1].
Since 2025, an emergency transport that uses a prehospital blood transfusion has qualified as ALS2 under Medicare and TRICARE[1]. CMS added the transfusion to the ALS2 procedure list in its Medicare Benefit Policy Manual to match its calendar year 2025 physician fee schedule final rule[2]. Trade publication JEMS reported at the time that no additional funding had been specifically allocated to blood products, and that reimbursement limits could make carrying them financially challenging for EMS clinicians[3].
The Defense Health Agency says its initial analysis suggests the ALS2 rate may not cover the cost[1]. The ALS2 rate is $237 higher than the ALS1 rate, and the notice says the cost of low-titer type O whole blood, the product typically carried in ambulances, exceeds that difference. That difference also has to pay for the other services an ALS2 patient receives[1]. To reach ALS2 in 2025, a crew had to give at least three separate intravenous medications or perform one of eight listed procedures, among them manual defibrillation, intubation, chest decompression and, now, a blood transfusion[1]. The notice cites one researcher’s estimate of about $925 per patient and a 2024 survey in which more than 70 percent of responding EMS agencies reported costs above $500 per unit and over a third reported costs above $800[1].
Under the demonstration, the add-on applies to low-titer O positive and O negative whole blood, packed red blood cells, plasma, or a combination of red cells and plasma given during an ALS2, specialty care or air transport[1]. The agency will pay the highest of two amounts: the hospital outpatient rate for the blood product, currently $189.84 a unit for whole blood billed under code P9010, or the blood bank’s invoiced cost if the provider submits an invoice[1]. Providers who do not submit an invoice are paid the outpatient rate[1].
Providers may also bill once per transport for the transfusion itself, under CPT code 36430, at a rate of about $40[1]. Supplies such as fluid warmers are not paid separately[1].
Why Medicare does not pay ambulances separately for blood
The demonstration grows out of a Medicare decision from late 2024. In its calendar year 2025 physician fee schedule proposal, published in July 2024, CMS offered to make a transfusion of low-titer O positive whole blood an ALS2 procedure in its own right[3, 4]. Before then, a crew that gave blood but provided no other qualifying service could not bill at the higher level[4].
The final rule, published Dec. 9, 2024, went further after public comment. It added O negative whole blood, packed red cells, plasma and the red cell and plasma combination, reasoning that each requires the same handling, training and equipment, such as a blood warmer and rapid infuser[4]. It took effect Jan. 1, 2025[3]. CMS also wrote that it does “not have the authority to provide an additional payment, such as an add-on payment” for whole blood under the ambulance fee schedule[4]. That left a higher bundled rate and no separate line for the blood itself.
The rule traced the practice to the wars in Iraq and Afghanistan, where data on casualties given fresh whole blood showed better survival than with standard component therapy and drew civilian trauma programs to the method[4]. Civilian use began in 2017 with two EMS systems in Texas, CMS said, and as of March 2024 about 147 EMS systems, 1.2 percent of the national total, carried whole blood products[4].
The Defense Health Agency notice says the change responds to “recent Federal action and significant stakeholder feedback”[1]. It names America’s Blood Centers, the Association for the Advancement of Blood & Biotherapies and the Prehospital Blood Transfusion Initiative Coalition as groups that argued the bundled Medicare payment is financially unsustainable for most EMS agencies, because it does not cover blood products, initial equipment or annual program upkeep[1]. The agency adds that civilian EMS agencies are increasingly seeking to adopt the practice, which it describes as pioneered by military medicine, but that “not all TRICARE beneficiaries have access to PHBT”[1].
The Defense Health Agency is working under a different authority. Its notice relies on 10 U.S.C. 1092, which lets the department run demonstration projects that test other ways to pay for and deliver care[1]. The agency concedes the right add-on is hard to set: it writes that the size of the reimbursement gap under ALS2 “is unclear” and that published cost figures vary widely by transport[1]. It chose a two-tier add-on, it says, because that is the simplest to run and gives providers and the department predictable payments[1].
Which TRICARE plans does the blood add-on cover?
Eligible beneficiaries are those in TRICARE Prime, including active-duty service members, TRICARE Select and TRICARE For Life, including people enrolled in a Medicare Advantage plan[1]. The notice excludes the Uniformed Services Family Health Plan, the Competitive Plans Demonstration, claims from outside the 50 states and territories, and beneficiaries whose other health insurance pays first[1]. Participating providers must be TRICARE-authorized ground or air ambulance companies, as defined in 32 CFR 199.6, that are licensed to give blood[1].
Will TRICARE beneficiaries pay more for ambulance blood?
Beneficiaries pay the deductibles, copayments and cost shares that apply to their plan[1]. Because most ambulance providers are out of network and out-of-network copayments are a percentage of the allowed amount, the notice says beneficiaries “may experience increases in their out-of-pocket costs” because the allowed amounts rise[1].
TRICARE For Life is a special case. By statute, TRICARE payment for those beneficiaries is limited to what remains after Medicare pays, which would leave them responsible for 75 percent or more of a new add-on, according to the notice[1]. For the demonstration, the agency will pay the add-on without that limit, but TRICARE For Life beneficiaries will have a 25 percent copayment on it[1]. If the agency later wants a permanent add-on for them, it says, Congress would have to change 10 U.S.C. 1086(d)(3); otherwise they would be left out of a permanent version[1].
Cost and evaluation
The agency estimates about $100,000 in administrative costs, $4.6 million in health care costs over five years and $500,000 for the evaluation, and says the figures are uncertain because uptake is hard to predict[1]. In year five it will ask four questions: whether the add-on improved outcomes for patients in hemorrhagic shock, lowered total cost of care, widened access to prehospital blood or the ambulance network, and proved workable to administer[1]. The review will rest mainly on retrospective claims data, an approach the agency says limits what it can conclude about cause and effect[1].
The Director of the Defense Health Agency may end or change the demonstration at any time. The notice lists minimal use, such as fewer than 250 claims in one year, as one possible reason, along with changes in Medicare’s payment method or a lack of evidence the add-on is working[1]. Changes and any extension would appear in the TRICARE Manuals; an early end would be announced in a new Federal Register notice[1].
If you’re affected
The demonstration begins Jan. 1, 2027, and the Defense Health Agency says it will publish implementation details in the TRICARE Manuals at manuals.health.mil[1]. Questions about the notice can go to Ms. Elan Green at (303) 676-3907, the contact the notice lists[1]. Beneficiaries do not apply for the add-on; it is a payment to the ambulance provider, and the notice describes no enrollment step for patients[1].
Readers ask
- When will TRICARE start paying ambulances extra for blood transfusions?
- On Jan. 1, 2027. The Defense Health Agency demonstration is set to run five years, through Dec. 31, 2031, unless the agency extends, changes or ends it early[1].
- How much will TRICARE pay an ambulance for a unit of prehospital blood?
- The add-on is the higher of the hospital outpatient rate for the product, now $189.84 a unit of whole blood, or what the blood supplier charged, when the ambulance company sends that invoice with its claim[1]. Providers can also bill about $40 once per transport for giving the transfusion[1].
- Will TRICARE For Life beneficiaries owe a copay on the ambulance blood add-on?
- Yes. Under the demonstration, TRICARE For Life beneficiaries owe 25 percent of the TRICARE allowed amount for the add-on, rather than having their share capped at what Medicare would leave them[1].
- Do TRICARE beneficiaries need to sign up for the prehospital blood demonstration?
- No. The money goes to the ambulance company, and patients have nothing to file or join[1]. Uniformed Services Family Health Plan members, people whose other insurance pays first and care outside the 50 states and territories are excluded[1].
Sources
- TRICARE Demonstration Project for TRICARE Ambulance Add-On Reimbursement for Pre-Hospital Blood Transfusion (FR Doc. 2026-13515). Department of Defense, Federal Register, July 6, 2026.
- Medicare Benefit Policy Manual transmittal R13169BP: prehospital blood transfusion added to the ALS2 list. Centers for Medicare & Medicaid Services, April 17, 2025.
- CMS Updates the ALS2 Definition to Include Additional Blood Products. JEMS, November 12, 2024.
- Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule (final rule, FR Doc. 2024-25382), section on low titer O+ whole blood transfusion therapy during ground ambulance transport. Federal Register (Centers for Medicare & Medicaid Services final rule), December 9, 2024.
A note on sourcing
This report rests on the Defense Health Agency’s notice as published in the Federal Register on July 6, 2026, with background from the Medicare rule that made prehospital transfusion an ALS2 service. The notice gives two figures for what Medicare and TRICARE pay hospitals for a unit of blood, about $225 and a current $189.84, and does not explain the difference. It also says the Defense Health Agency will publish implementing details in the TRICARE Manuals, which had not appeared as of publication, so claim-filing procedures are not yet known. The agency’s own cost estimate carries what it calls substantial uncertainty. Counts of EMS systems carrying blood are the figures CMS cited in its December 2024 rule and may have changed since. The piece does not include comment from ambulance operators, blood suppliers or military and veterans organizations.
Filed underTRICARE · ambulance · Defense Health Agency · TRICARE For Life · demonstration project
Return to THE FRONT PAGE